Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
Clinical trial NCT05347212 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05347212
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-22
- Primary completion
- 2027-07-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.